메뉴 건너뛰기




Volumn 45, Issue 5, 2014, Pages 2101-2107

Epigenetic silencing of ARNTL, a circadian gene and potential tumor suppressor in ovarian cancer

Author keywords

ARNTL; Circadian clock; Epigenetic modifications; Ovarian cancer; Tumor suppressor

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; ANTINEOPLASTIC AGENT; BISULFITE; CISPLATIN; DNA METHYLTRANSFERASE INHIBITOR; GSK 126; TRANSCRIPTION FACTOR ARNTL; TRANSCRIPTION FACTOR EZH2; UNCLASSIFIED DRUG; ARNTL PROTEIN, HUMAN; HISTONE;

EID: 84907197942     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2014.2627     Document Type: Article
Times cited : (61)

References (42)
  • 2
    • 84870328109 scopus 로고    scopus 로고
    • Exercise strengthens circadian clocks
    • Harrington ME: Exercise strengthens circadian clocks. J Physiol 590: 5929, 2012.
    • (2012) J Physiol , vol.590 , pp. 5929
    • Harrington, M.E.1
  • 3
    • 0041346143 scopus 로고    scopus 로고
    • Circadian rhythms. Clocks on the brain
    • Green CB and Menaker M: Circadian rhythms. Clocks on the brain. Science 301: 319-320, 2003.
    • (2003) Science , vol.301 , pp. 319-320
    • Green, C.B.1    Menaker, M.2
  • 4
    • 0032956319 scopus 로고    scopus 로고
    • Cellular circadian clocks in the pineal
    • Falcon J: Cellular circadian clocks in the pineal. Prog Neurobiol 58: 121-162, 1999.
    • (1999) Prog Neurobiol , vol.58 , pp. 121-162
    • Falcon, J.1
  • 5
    • 0034982529 scopus 로고    scopus 로고
    • Light in the built environment: Potential role of circadian disruption in endocrine disruption and breast cancer
    • Stevens RG and Rea MS: Light in the built environment: Potential role of circadian disruption in endocrine disruption and breast cancer. Cancer Causes Control 12: 279-287, 2001.
    • (2001) Cancer Causes Control , vol.12 , pp. 279-287
    • Stevens, R.G.1    Rea, M.S.2
  • 6
    • 33645498504 scopus 로고    scopus 로고
    • Risk of breast cancer after night-and shift work: Current evidence and ongoing studies in Denmark
    • Hansen J: Risk of breast cancer after night-and shift work: Current evidence and ongoing studies in Denmark. Cancer Causes Control 17: 531-537, 2006.
    • (2006) Cancer Causes Control , vol.17 , pp. 531-537
    • Hansen, J.1
  • 7
    • 0037704257 scopus 로고    scopus 로고
    • Night-shift work and risk of colorectal cancer in the nurses' health study
    • Schernhammer ES, Laden F, Speizer FE, et al: Night-shift work and risk of colorectal cancer in the nurses' health study. J Natl Cancer Inst 95: 825-828, 2003.
    • (2003) J Natl Cancer Inst , vol.95 , pp. 825-828
    • Schernhammer, E.S.1    Laden, F.2    Speizer, F.E.3
  • 8
    • 0345707584 scopus 로고    scopus 로고
    • The days and nights of cancer cells
    • Canaple L, Kakizawa T and Laudet V: The days and nights of cancer cells. Cancer Res 63: 7545-7552, 2003.
    • (2003) Cancer Res , vol.63 , pp. 7545-7552
    • Canaple, L.1    Kakizawa, T.2    Laudet, V.3
  • 9
    • 27944472296 scopus 로고    scopus 로고
    • Circadian function in patients with advanced non-small-cell lung cancer
    • Levin RD, Daehler MA, Grutsch JF, et al: Circadian function in patients with advanced non-small-cell lung cancer. Br J Cancer 93: 1202-1208, 2005.
    • (2005) Br J Cancer , vol.93 , pp. 1202-1208
    • Levin, R.D.1    Daehler, M.A.2    Grutsch, J.F.3
  • 10
    • 77953520230 scopus 로고    scopus 로고
    • Circadian rhythms and cancer
    • Gery S and Koeffler HP: Circadian rhythms and cancer. Cell Cycle 9: 1097-1103, 2010.
    • (2010) Cell Cycle , vol.9 , pp. 1097-1103
    • Gery, S.1    Koeffler, H.P.2
  • 11
    • 84863494541 scopus 로고    scopus 로고
    • Correlation of the risk of breast cancer and disruption of the circadian rhythm (Review)
    • Leonardi GC, Rapisarda V, Marconi A, et al: Correlation of the risk of breast cancer and disruption of the circadian rhythm (Review). Oncol Rep 28: 418-428, 2012.
    • (2012) Oncol Rep , vol.28 , pp. 418-428
    • Leonardi, G.C.1    Rapisarda, V.2    Marconi, A.3
  • 12
    • 80053102580 scopus 로고    scopus 로고
    • Disrupting the circadian clock: Genespecific effects on aging, cancer, and other phenotypes
    • Yu EA and Weaver DR: Disrupting the circadian clock: Genespecific effects on aging, cancer, and other phenotypes. Aging (Albany, NY) 3: 479-493, 2011.
    • (2011) Aging (Albany, NY) , vol.3 , pp. 479-493
    • Yu, E.A.1    Weaver, D.R.2
  • 13
    • 77950408376 scopus 로고    scopus 로고
    • Circadian rhythm and its role in malignancy
    • Rana S and Mahmood S: Circadian rhythm and its role in malignancy. J Circadian Rhythms 8: 3, 2010.
    • (2010) J Circadian Rhythms , vol.8 , pp. 3
    • Rana, S.1    Mahmood, S.2
  • 14
    • 77950903271 scopus 로고    scopus 로고
    • Circadian clocks and vascular function
    • Paschos GK and FitzGerald GA: Circadian clocks and vascular function. Circ Res 106: 833-841, 2010.
    • (2010) Circ Res , vol.106 , pp. 833-841
    • Paschos, G.K.1    FitzGerald, G.A.2
  • 15
    • 52149109334 scopus 로고    scopus 로고
    • The genetics of mammalian circadian order and disorder: Implications for physiology and disease
    • Takahashi JS, Hong HK, Ko CH and McDearmon EL: The genetics of mammalian circadian order and disorder: Implications for physiology and disease. Nat Rev Genet 9: 764-775, 2008.
    • (2008) Nat Rev Genet , vol.9 , pp. 764-775
    • Takahashi, J.S.1    Hong, H.K.2    Ko, C.H.3    McDearmon, E.L.4
  • 16
    • 34247515224 scopus 로고    scopus 로고
    • Riding tandem: Circadian clocks and the cell cycle
    • Hunt T and Sassone-Corsi P: Riding tandem: Circadian clocks and the cell cycle. Cell 129: 461-464, 2007.
    • (2007) Cell , vol.129 , pp. 461-464
    • Hunt, T.1    Sassone-Corsi, P.2
  • 17
    • 33644617485 scopus 로고    scopus 로고
    • Rhythmic CLOCK-BMAL1 binding to multiple E-box motifs drives circadian Dbp transcription and chromatin transitions
    • Ripperger JA and Schibler U: Rhythmic CLOCK-BMAL1 binding to multiple E-box motifs drives circadian Dbp transcription and chromatin transitions. Nat Genet 38: 369-374, 2006.
    • (2006) Nat Genet , vol.38 , pp. 369-374
    • Ripperger, J.A.1    Schibler, U.2
  • 18
    • 83655184641 scopus 로고    scopus 로고
    • Altered expression of circadian clock genes in head and neck squamous cell carcinoma
    • Hsu CM, Lin SF, Lu CT, Lin PM and Yang MY: Altered expression of circadian clock genes in head and neck squamous cell carcinoma. Tumour Biol 33: 149-155, 2012.
    • (2012) Tumour Biol , vol.33 , pp. 149-155
    • Hsu, C.M.1    Lin, S.F.2    Lu, C.T.3    Lin, P.M.4    Yang, M.Y.5
  • 19
    • 53849124685 scopus 로고    scopus 로고
    • Clinicopathological significance of circadian rhythm-related gene expression levels in patients with epithelial ovarian cancer
    • Tokunaga H, Takebayashi Y, Utsunomiya H, et al: Clinicopathological significance of circadian rhythm-related gene expression levels in patients with epithelial ovarian cancer. Acta Obstet Gynecol Scand 87: 1060-1070, 2008.
    • (2008) Acta Obstet Gynecol Scand , vol.87 , pp. 1060-1070
    • Tokunaga, H.1    Takebayashi, Y.2    Utsunomiya, H.3
  • 20
    • 33750377047 scopus 로고    scopus 로고
    • Downregulation of circadian clock genes in chronic myeloid leukemia: Alternative methylation pattern of hPER3
    • Yang MY, Chang JG, Lin PM, et al: Downregulation of circadian clock genes in chronic myeloid leukemia: Alternative methylation pattern of hPER3. Cancer Sci 97: 1298-1307, 2006.
    • (2006) Cancer Sci , vol.97 , pp. 1298-1307
    • Yang, M.Y.1    Chang, J.G.2    Lin, P.M.3
  • 21
    • 80053144962 scopus 로고    scopus 로고
    • A decade of exploring the cancer epigenome -biological and translational implications
    • Baylin SB and Jones PA: A decade of exploring the cancer epigenome -biological and translational implications. Nat Rev Cancer 11: 726-734, 2011.
    • (2011) Nat Rev Cancer , vol.11 , pp. 726-734
    • Baylin, S.B.1    Jones, P.A.2
  • 22
    • 84879249639 scopus 로고    scopus 로고
    • Conceptual links between DNA methylation reprogramming in the early embryo and primordial germ cells
    • Seisenberger S, Peat JR and Reik W: Conceptual links between DNA methylation reprogramming in the early embryo and primordial germ cells. Curr Opin Cell Biol 25: 281-288, 2013.
    • (2013) Curr Opin Cell Biol , vol.25 , pp. 281-288
    • Seisenberger, S.1    Peat, J.R.2    Reik, W.3
  • 23
    • 33748297582 scopus 로고    scopus 로고
    • Histone modifications silence the GATA transcription factor genes in ovarian cancer
    • Caslini C, Capo-chichi CD, Roland IH, Nicolas E, Yeung AT and Xu XX: Histone modifications silence the GATA transcription factor genes in ovarian cancer. Oncogene 25: 5446-5461, 2006.
    • (2006) Oncogene , vol.25 , pp. 5446-5461
    • Caslini, C.1    Capo-chichi, C.D.2    Roland, I.H.3    Nicolas, E.4    Yeung, A.T.5    Xu, X.X.6
  • 24
    • 0037354548 scopus 로고    scopus 로고
    • Epigenetic regulation of ARHI in breast and ovarian cancer cells
    • Yu Y, Fujii S, Yuan J, et al: Epigenetic regulation of ARHI in breast and ovarian cancer cells. Ann NY Acad Sci 983: 268-277, 2003.
    • (2003) Ann NY Acad Sci , vol.983 , pp. 268-277
    • Yu, Y.1    Fujii, S.2    Yuan, J.3
  • 25
    • 27144499187 scopus 로고    scopus 로고
    • Hypermethylation of 18S and 28S ribosomal DNAs predicts progression-free survival in patients with ovarian cancer
    • Chan MW, Wei SH, Wen P, et al: Hypermethylation of 18S and 28S ribosomal DNAs predicts progression-free survival in patients with ovarian cancer. Clin Cancer Res 11: 7376-7383, 2005.
    • (2005) Clin Cancer Res , vol.11 , pp. 7376-7383
    • Chan, M.W.1    Wei, S.H.2    Wen, P.3
  • 26
    • 50849154478 scopus 로고    scopus 로고
    • Aberrant transforming growth factor beta1 signaling and SMAD4 nuclear translocation confer epigenetic repression of ADAM19 in ovarian cancer
    • Chan MW, Huang YW, Hartman-Frey C, et al: Aberrant transforming growth factor beta1 signaling and SMAD4 nuclear translocation confer epigenetic repression of ADAM19 in ovarian cancer. Neoplasia 10: 908-919, 2008.
    • (2008) Neoplasia , vol.10 , pp. 908-919
    • Chan, M.W.1    Huang, Y.W.2    Hartman-Frey, C.3
  • 27
    • 77649092118 scopus 로고    scopus 로고
    • Promoter hypermethylation of FBXO32, a novel TGF-beta/SMAD4 target gene and tumor suppressor, is associated with poor prognosis in human ovarian cancer
    • Chou JL, Su HY, Chen LY, et al: Promoter hypermethylation of FBXO32, a novel TGF-beta/SMAD4 target gene and tumor suppressor, is associated with poor prognosis in human ovarian cancer. Lab Invest 90: 414-425, 2010.
    • (2010) Lab Invest , vol.90 , pp. 414-425
    • Chou, J.L.1    Su, H.Y.2    Chen, L.Y.3
  • 28
    • 79958741371 scopus 로고    scopus 로고
    • Aberrant TGFbeta/SMAD4 signaling contributes to epigenetic silencing of a putative tumor suppressor, RunX1T1 in ovarian cancer
    • Yeh KT, Chen TH, Yang HW, et al: Aberrant TGFbeta/SMAD4 signaling contributes to epigenetic silencing of a putative tumor suppressor, RunX1T1 in ovarian cancer. Epigenetics 6: 727-739, 2011.
    • (2011) Epigenetics , vol.6 , pp. 727-739
    • Yeh, K.T.1    Chen, T.H.2    Yang, H.W.3
  • 29
    • 58249087346 scopus 로고    scopus 로고
    • An epigenetic marker panel for screening and prognostic prediction of ovarian cancer
    • Su HY, Lai HC, Lin YW, Chou YC, Liu CY and Yu MH: An epigenetic marker panel for screening and prognostic prediction of ovarian cancer. Int J Cancer 124: 387-393, 2009.
    • (2009) Int J Cancer , vol.124 , pp. 387-393
    • Su, H.Y.1    Lai, H.C.2    Lin, Y.W.3    Chou, Y.C.4    Liu, C.Y.5    Yu, M.H.6
  • 30
    • 0037105657 scopus 로고    scopus 로고
    • Periostin secreted by epithelial ovarian carcinoma is a ligand for aVβ3 and aVβ5 integrins and promotes cell motility
    • Gillan L, Matei D, Fishman DA, Gerbin CS, Karlan BY and Chang DD: Periostin secreted by epithelial ovarian carcinoma is a ligand for aVβ3 and aVβ5 integrins and promotes cell motility. Cancer Res 62: 5358-5364, 2002.
    • (2002) Cancer Res , vol.62 , pp. 5358-5364
    • Gillan, L.1    Matei, D.2    Fishman, D.A.3    Gerbin, C.S.4    Karlan, B.Y.5    Chang, D.D.6
  • 31
    • 84870573126 scopus 로고    scopus 로고
    • EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
    • McCabe MT, Ott HM, Ganji G, et al: EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations. Nature 492: 108-112, 2012.
    • (2012) Nature , vol.492 , pp. 108-112
    • McCabe, M.T.1    Ott, H.M.2    Ganji, G.3
  • 32
    • 0037184940 scopus 로고    scopus 로고
    • The circadian gene period2 plays an important role in tumor suppression and DNA-damage response in vivo
    • Fu LN, Pelicano H, Liu JS, Huang P and Lee CC: The circadian gene period2 plays an important role in tumor suppression and DNA-damage response in vivo. Cell 111: 1055-1055, 2002.
    • (2002) Cell , vol.111 , pp. 1055-1055
    • Fu, L.N.1    Pelicano, H.2    Liu, J.S.3    Huang, P.4    Lee, C.C.5
  • 33
    • 0037711399 scopus 로고    scopus 로고
    • The circadian clock: Pacemaker and tumour suppressor
    • Fu L and Lee CC: The circadian clock: Pacemaker and tumour suppressor. Nat Rev Cancer 3: 350-361, 2003.
    • (2003) Nat Rev Cancer , vol.3 , pp. 350-361
    • Fu, L.1    Lee, C.C.2
  • 34
    • 53349145764 scopus 로고    scopus 로고
    • The circadian gene NPAS2, a putative tumor suppressor, is involved in DNA damage response
    • Hoffman AE, Zheng T, Ba Y and Zhu Y: The circadian gene NPAS2, a putative tumor suppressor, is involved in DNA damage response. Mol Cancer Res 6: 1461-1468, 2008.
    • (2008) Mol Cancer Res , vol.6 , pp. 1461-1468
    • Hoffman, A.E.1    Zheng, T.2    Ba, Y.3    Zhu, Y.4
  • 35
    • 33947422161 scopus 로고    scopus 로고
    • Epigenetic silencing of the candidate tumor suppressor gene Per1 in non-small cell lung cancer
    • Gery S, Komatsu N, Kawamata N, et al: Epigenetic silencing of the candidate tumor suppressor gene Per1 in non-small cell lung cancer. Clin Cancer Res 13: 1399-1404, 2007.
    • (2007) Clin Cancer Res , vol.13 , pp. 1399-1404
    • Gery, S.1    Komatsu, N.2    Kawamata, N.3
  • 36
    • 70350539563 scopus 로고    scopus 로고
    • Epigenetic inactivation of the circadian clock gene BMAL1 in hematologic malignancies
    • Taniguchi H, Fernandez AF, Setien F, et al: Epigenetic inactivation of the circadian clock gene BMAL1 in hematologic malignancies. Cancer Res 69: 8447-8454, 2009.
    • (2009) Cancer Res , vol.69 , pp. 8447-8454
    • Taniguchi, H.1    Fernandez, A.F.2    Setien, F.3
  • 37
    • 33749259773 scopus 로고    scopus 로고
    • Promoter methylation in circadian genes of endometrial cancers detected by methylation-specific PCR
    • Shih MC, Yeh KT, Tang KP, Chen JC and Chang JG: Promoter methylation in circadian genes of endometrial cancers detected by methylation-specific PCR. Mol Carcinog 45: 732-740, 2006.
    • (2006) Mol Carcinog , vol.45 , pp. 732-740
    • Shih, M.C.1    Yeh, K.T.2    Tang, K.P.3    Chen, J.C.4    Chang, J.G.5
  • 38
    • 62849106294 scopus 로고    scopus 로고
    • A large scale shRNA barcode screen identifies the circadian clock component ARNTL as putative regulator of the p53 tumor suppressor pathway
    • Mullenders J, Fabius AW, Madiredjo M, Bernards R and Beijersbergen RL: A large scale shRNA barcode screen identifies the circadian clock component ARNTL as putative regulator of the p53 tumor suppressor pathway. PloS one 4: E4798, 2009.
    • (2009) PloS one , vol.4 , pp. e4798
    • Mullenders, J.1    Fabius, A.W.2    Madiredjo, M.3    Bernards, R.4    Beijersbergen, R.L.5
  • 39
    • 84876254318 scopus 로고    scopus 로고
    • Bmal1 suppresses cancer cell invasion by blocking the phosphoinositide 3-kinase-Akt-MMP-2 signaling pathway
    • Jung CH, Kim EM, Park JK, et al: Bmal1 suppresses cancer cell invasion by blocking the phosphoinositide 3-kinase-Akt-MMP-2 signaling pathway. Oncol Rep 29: 2109-2113, 2013.
    • (2013) Oncol Rep , vol.29 , pp. 2109-2113
    • Jung, C.H.1    Kim, E.M.2    Park, J.K.3
  • 40
    • 18644382388 scopus 로고    scopus 로고
    • The polycomb group protein EZH2 is involved in progression of prostate cancer
    • Varambally S, Dhanasekaran SM, Zhou M, et al: The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 419: 624-629, 2002.
    • (2002) Nature , vol.419 , pp. 624-629
    • Varambally, S.1    Dhanasekaran, S.M.2    Zhou, M.3
  • 41
    • 0141816752 scopus 로고    scopus 로고
    • EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells
    • Kleer CG, Cao Q, Varambally S, et al: EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells. Proc Natl Acad Sci USA 100: 11606-11611, 2003.
    • (2003) Proc Natl Acad Sci USA , vol.100 , pp. 11606-11611
    • Kleer, C.G.1    Cao, Q.2    Varambally, S.3
  • 42
    • 32844459336 scopus 로고    scopus 로고
    • The Polycomb group protein EZH2 directly controls DNA methylation
    • Vire E, Brenner C, Deplus R, et al: The Polycomb group protein EZH2 directly controls DNA methylation. Nature 439: 871-874, 2006.
    • (2006) Nature , vol.439 , pp. 871-874
    • Vire, E.1    Brenner, C.2    Deplus, R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.